Sun.Oct 27, 2024

article thumbnail

Lion’s Mane Mushroom: Nature’s Ally for Brain Health, Mental Clarity and Menopause Support

Alison Bladh

Lion’s Mane Mushroom: Nature’s Ally for Brain Health, Mental Clarity, and Menopause Support As we journey through our 40s and beyond, the importance of cognitive health and mental clarity becomes unmistakably clear. Many women entering perimenopause or menopause experience brain fog, memory lapses, and mood fluctuations, leading them to seek natural ways to support brain function, focus, and overall vitality.

Diet 98
article thumbnail

Study Reveals Comparable Efficacy of Clascoterone, Trifarotene, and Tazarotene in Acne Treatment

Dermatology Times

The recent meta-analysis revealed comparable efficacy in treating acne vulgaris and was presented at Fall Clinical 2024.

article thumbnail

U.S. Dermatology Partners Recognized as Best Dermatology Practice in the Best of McKinney 2024 Star Local Media Reader’s Choice Contest

US Dermatologt Partners

McKinney, Texas – U.S. Dermatology Partners is Recognized as Best Dermatology Practice in The Best of McKinney 2024 Star Local Media Reader’s Choice Contest. U.S. Dermatology Partners is Recognized in the Best of McKinney 2024 Star Local Media Reader’s Choice Contest U.S. Dermatology Partners is thrilled to announce that its McKinney, Texas location has been voted the Best Dermatology Practice in The Best of McKinney 2024 Star Local Media Reader’s Choice Content!

article thumbnail

Elevating Standards in Atopic Dermatitis Through JAK Inhibitors and Optimal Treatment Targets

Dermatology Times

At Fall Clinical 2024, Christopher Bunick, MD, PhD, discussed systemic therapy options and the importance of comprehensive treatment targets in managing atopic dermatitis, emphasizing AHEAD recommendations and LEVEL UP data.

article thumbnail

Glynis Ablon, MD, Spotlights Top Devices and Innovations in Aesthetic Dermatology

Dermatology Times

At Fall Clinical 2024, Ablon shared her top device-based interventions, from wound care to radiofrequency rejuvenation, revealing clinical pearls for enhanced aesthetic outcomes.

article thumbnail

Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis

Dermatology Times

Deucravacitinib demonstrated significant efficacy and safety in treating moderate to severe scalp psoriasis, as shown in the PSORIATYK SCALP trial presented at Fall Clinical.

Safety 36

More Trending

article thumbnail

Emmy Graber, MB, MBA, Shares Top Clinical Pearls on Lasers, Erythema Treatments, and Emerging Therapies

Dermatology Times

At Fall Clinical 2024, Graber spotlighted precise acne-targeting lasers, new combination creams, and a promising rosacea pill awaiting FDA approval.

Clinic 36
article thumbnail

James Song, MD, FAAD: Advanced Strategies for Alopecia Areata, Refractory Dermatoses, and Emerging Non-Steroidal Topicals

Dermatology Times

Song shared top clinical tips at Fall Clinical, covering alopecia areata, refractory dermatoses, and novel non-steroidal topicals.

Clinic 36
article thumbnail

Day 4 Recap: Fall Clinical 2024

Dermatology Times

Catch up on coverage from the final day of the 2024 Fall Clinical Dermatology Conference in Las Vegas, Nevada.

Clinic 36